Coronavirus (COVID-19) News
Filter News
Found 2,648 articles
-
Burjeel Holdings and BridgeBio Pharma ink partnership deal in rare genetic diseases with a plan to set up headquarters in Abu Dhabi.
-
The biotech will supply Canada with fewer doses of its coronavirus vaccine while reaching a financial agreement for the forfeiting of certain doses previously scheduled for delivery.
-
Revive Therapeutics Announces Results of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19
7/6/2023
Revive Therapeutics Ltd. announced results of the Company’s Phase 3 clinical trial evaluating the safety and efficacy of oral Bucillamine in patients with mild to moderate COVID-19.
-
Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs
7/6/2023
NanoViricides, Inc. reports that the clinical trial of its broad-spectrum antiviral drug NV-CoV-2 is progressing satisfactorily.
-
The company has signed a memorandum of understanding and land collaboration agreement to develop medicines exclusively for Chinese use.
-
LumiraDx Submits First 510(k) Application to the FDA for COVID Ultra Test
6/30/2023
LumiraDx Limited, a leading innovator in diagnostic technologies, announced the submission of its first 510 application to the U.S. Food and Drug Administration for the clearance of its ground-breaking 5-minute COVID Ultra Test.
-
Results Show Treatment With Ondine’s Nasal Photodisinfection Dramatically Reduced Covid-19 Rates at Canadian Meat Processing Plant
6/22/2023
Newly published research in the journal Public Health Practice shows that a weekly program of nasal photodisinfection implemented at a major Western Canada meat packing plant, alongside standard safety measures recommended by the US Centre for Diseases Control and Prevention, reduced the expected COVID-19 positivity rate by over 99%, from 1,344 expected positive PCR tests to 3 positive PCR tests out of over 21,000 administered tests over a seven-month period.
-
While the German biotech that partnered with Pfizer on a COVID vaccine sees its first lawsuit, legal experts don’t expect similar cases in the U.S.
-
‘Negative Evidence’ Regarding COVID Vaccines and Sudden Death Reviewed in Journal of American Physicians and Surgeons
6/19/2023
The controversial 2022 video Died Suddenly has sparked devastating criticisms from both COVID vaccine proponents and skeptics, but the question remains: Are the vaccines a potential cause of otherwise unexplained sudden death? In the summer issue of the Journal of American Physicians and Surgeons, Jane Orient, M.D., explores possible causes of this terrifying event.
-
New Tests Yield Actionable Insights
6/19/2023
Quest collaborated with Coriell Life Sciences to offer select medical plan members pharmacogenomics testing services indicating how specific genes and their variations impact a person's response to medications.
-
In a unanimous 21-0 vote, an FDA advisory committee recommended an updated monovalent formulation of the COVID-19 vaccine targeting the now-dominant XBB.1.5 subvariant.
-
Novavax Prepared to Deliver Protein-based Monovalent XBB COVID Vaccine Consistent with FDA VRBPAC Recommendation for the Fall
6/15/2023
Novavax, Inc. participated in U.S. Food and Drug Administration Vaccines and Related Biological Products Advisory Committee's meeting, which resulted in a unanimous vote recommending updating the current COVID vaccine composition to a monovalent XBB-lineage.
-
Moat Biotechnology Raises $6.5M in First Close for Intranasal/Inhaled Covid-19 Vaccine
6/13/2023
The first U.S.-based company with promising proof of concept for intranasal/inhaled adenovirus vaccines, Moat Biotechnology Corporation, announces it has raised more than $6.5 million in its first close of funding.
-
Bioxytran Expands Institutional Investor Base with an additional $500,000 Equity Investment
6/12/2023
BIOXYTRAN, INC. announced that it has entered into a common stock purchase agreement with TRITON FUNDS LP for $500,000.
-
Many long COVID patients suffer from persistent inflammation, study finds
6/12/2023
An overactive inflammatory response could be at the root of many long COVID cases, according to a new study from the Allen Institute and Fred Hutchinson Cancer Center.
-
Government of Canada Supports Research on COVID-19 Treatments for Transplant Recipients
6/9/2023
The Government of Canada recognizes the lifesaving impact that organ donation has on those in need of a transplantation.
-
China Approves the World's First Vaccine against XBB Descendent Lineages of SARS-CoV-2 for Emergency Use
6/9/2023
On June 8th, 2023, Coviccine® Trivalent XBB.1.5-Recombinant COVID-19 Trivalent Protein Vaccine developed by WestVac Biopharma/ West China Medical Center, Sichuan University was approved for EUA by relevant authorities in China.
-
Promosome filed lawsuits Tuesday against Moderna and Pfizer/BioNTech, alleging that the vaccine developers used patent-protected mRNA technology without a license.
-
COVID-19 vaccination: No serious side effects in young children
6/6/2023
A review of more than 245,000 doses of mRNA COVID-19 vaccines given to young children found no indications of serious side effects.
-
Congressman Scott Peters Tours Maravai’s RNA manufacturing facility
6/6/2023
Maravai LifeSciences, Inc., a global provider of life science reagents and services to researchers and biotech innovators, recently hosted Congressman Scott Peters for a tour of the RNA manufacturing facility at Wateridge Circle in San Diego.